People · Operator
Named in public records as an officer, director or promoter · active 2009–2020 · Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Spruce Biosciences, Inc. | — | Biotechnology | Series C | $191.6M | $274.3M | 2020 |
| Talphera, Inc. | — | Pharmaceuticals | Series B | $97.4M | $74.1M | 2010 |
| Cortria Corp | — | Pharmaceuticals | Seed | $1.8M | $70.0M | 2009 |
Richard King at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Richard King on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Grey | 1 | 10 |
| Mark Wan | 1 | 10 |
| Brian Halak | 1 | 10 |
| Tiba Aynechi | 1 | 9 |
| Stephen Reeders | 1 | 9 |
| Stephen Hoffman | 1 | 7 |
| Niall O'Donnell | 1 | 7 |
| Guy Nohra | 1 | 5 |
| Howard Rosen | 1 | 5 |
| Mark Edwards | 1 | 4 |
| Howard B. Rosen | 1 | 4 |
| James Welch | 1 | 4 |
| Bali Muralidhar | 1 | 3 |
| James H. Welch | 1 | 3 |
| Marina Bozilenko | 1 | 3 |
| Daniel Grau | 1 | 3 |
| Jay Hachigian | 1 | 3 |
| Vincent J. Angotti | 1 | 2 |
| Guy B Nohra | 1 | 2 |
| Anil Dasu | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.